Literature DB >> 31007175

Outside the liver box: The gut microbiota as pivotal modulator of liver diseases.

Annika Wahlström1.   

Abstract

The gut microbiota affects host physiology and has evolved as an important contributor to health and disease. Gut and liver are closely connected and communicate via the portal vein and the biliary system so the liver is constantly exposed to gut-derived bacterial products and metabolites. The intestinal barrier is important for maintaining physical and functional separation between microbes in the gut and the interior of the host and disruption of the barrier function can lead to bacterial translocation and increased leakage of bacterial metabolites. Liver diseases have been associated with dysbiotic changes in the gut microbiota and impaired gut barrier integrity, thus a future strategy to treat liver disease may be to target the gut microbiota and thereby restore the gut barrier function. This review will summarize and discuss studies that have shown a link between the gut microbiota and liver disease with the main focus on non-alcoholic fatty liver disease and alcoholic liver disease.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcoholic liver disease; Cholestatic liver disease; Gut microbiota; Intestinal permeability; Liver disease; Non-alcoholic fatty liver disease

Mesh:

Year:  2018        PMID: 31007175     DOI: 10.1016/j.bbadis.2018.07.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  7 in total

1.  Role of Indole-3-Acetic Acid in NAFLD Amelioration After Sleeve Gastrectomy.

Authors:  Yu Wang; Geng Wang; Jie Bai; Ning Zhao; Qingbo Wang; Rui Zhou; Gang Li; Chaojie Hu; Xin Li; Kaixiong Tao; Zefeng Xia; Guobin Wang
Journal:  Obes Surg       Date:  2021-05-10       Impact factor: 4.129

2.  Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases.

Authors:  Heekyong R Bae; Patrick S C Leung; Deborah L Hodge; John M Fenimore; Seon-Min Jeon; Vishal Thovarai; Amiran Dzutsev; Andrew A Welcher; Michael Boedigheimer; Michael A Damore; Myung-Sook Choi; Richard A Fravell; Giorgio Trinchieri; M Eric Gershwin; Howard A Young
Journal:  J Autoimmun       Date:  2020-03-24       Impact factor: 7.094

Review 3.  Role of Gut Microbiota in Hepatocarcinogenesis.

Authors:  Haripriya Gupta; Gi Soo Youn; Min Jea Shin; Ki Tae Suk
Journal:  Microorganisms       Date:  2019-05-05

4.  Diet modulates cecum bacterial diversity and physiological phenotypes across the BXD mouse genetic reference population.

Authors:  Maria Elisa Perez-Munoz; Autumn M McKnite; Evan G Williams; Johan Auwerx; Robert W Williams; Daniel A Peterson; Daniel C Ciobanu
Journal:  PLoS One       Date:  2019-10-21       Impact factor: 3.240

Review 5.  Advanced Organ-on-a-Chip Devices to Investigate Liver Multi-Organ Communication: Focus on Gut, Microbiota and Brain.

Authors:  Lucia Boeri; Luca Izzo; Lorenzo Sardelli; Marta Tunesi; Diego Albani; Carmen Giordano
Journal:  Bioengineering (Basel)       Date:  2019-09-28

6.  Increase of Akkermansia muciniphila by a Diet Containing Japanese Traditional Medicine Bofutsushosan in a Mouse Model of Non-Alcoholic Fatty Liver Disease.

Authors:  Mitsue Nishiyama; Nobuhiro Ohtake; Atsushi Kaneko; Naoko Tsuchiya; Sachiko Imamura; Seiichi Iizuka; Shiori Ishizawa; Akinori Nishi; Masahiro Yamamoto; Akinobu Taketomi; Toru Kono
Journal:  Nutrients       Date:  2020-03-20       Impact factor: 5.717

Review 7.  A Perspective Of Intestinal Immune-Microbiome Interactions In Alcohol-Associated Liver Disease.

Authors:  Ryan Bruellman; Cristina Llorente
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.